Jiangsu Jibeier Pharmaceutical Investor Relations Material
Latest events
Q2 2025
30 Aug, 2025
Q4 2024
15 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jiangsu Jibeier Pharmaceutical
Access all reports
Jiangsu Jibeier Pharmaceutical Co., Ltd. is a China-based pharmaceutical company engaged in the research, development, production, and sale of pharmaceutical products. The company specializes in treatments for chronic and infectious diseases, providing a portfolio of products that includes antibiotics, antiviral drugs, and health supplements. The company is headquartered in Suzhou, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
688566
Country
🇨🇳 China